Receptor sites for complement and for immune complexes on human nonhemopoietic tumor cells.
Tumor cells in primary cultures derived from 11 untreated nonhemopoietic cancer patients were reacted with specifically coated sheep erythrocytes. Rosette formation between tumor and indicator cells was assessed, Eight of the primary cultures reacted positively with both IgG-coated (EAIgG) and with IgM-human complement coated (EAIgMC or EAIgMC 4,3) sheep erythrocytes. EAIgG rosette formation in positive cultures ranged from 25 to 85%, and for EAIgMC/EAIgMC 4,3 reactivity ranged between 22--95%. Rosette formation with E (uncoated) and EAIgM was negligible. These findings suggest that human nonhemopoietic tumor cells may carry on their surface receptor sites for an IgG component of immune complexes and for human complement. These receptor sites may be important in the host-tumor relationship.
D000230:Adenocarcinoma / Q000276:immunology; D000936:Antigen-Antibody Complex; D001665:Binding Sites; D002817:Chordoma / Q000276:immunology; D003165:Complement System Proteins; D004912:Erythrocytes / Q000276:immunology; D005770:Gastrointestinal Neoplasms / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008545:Melanoma / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*; D012397:Rosette Formation
D000936:Antigen-Antibody Complex; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D003165:Complement System Proteins